Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Perry Insider Profile
4 Followers
Andrew Perry, CCO at G1 Therapeutics, holds 0.00 shares in G1 Therapeutics (Ticker: GTHX).
Andrew Perry has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Andrew Perry does not currently own shares as a corporate insider.
A breakdown of Andrew Perry's holdings
Insider Roles
Andrew Perry does not currently hold a role as a corporate insider.
Roles that Andrew Perry holds in companies
Most Profitable Insider Trade
Stock:
G1 Therapeutics
(GTHX)
(GTHX)
Rating:Informative Sell
Date:Jan 05, 2023 - Jan 05, 2024
Return:+43.20%
The most profitable trade made by Andrew Perry
Andrew Perry's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Perry's performance on stock
You May Also Like
Andrew Perry insider profile FAQ
What is the percentage of profitable transactions made by Andrew Perry?
The percentage of profitable transactions made by Andrew Perry is ―.
What is the average return per transaction made by Andrew Perry?
The average return per transaction made by Andrew Perry is ―.
What stocks does Andrew Perry hold?
Andrew Perry holds: GTHX stocks.
What was Andrew Perry’s latest transaction?
Andrew Perry latest transaction was an Uninformative Buy of ―.
What was Andrew Perry's most profitable transaction?
Andrew Perry’s most profitable transaction was an Informative Sell of GTHX stock on January 5, 2023. The return on the trade was 43.20%.
What is Andrew Perry's role in G1 Therapeutics?
Andrew Perry's role in G1 Therapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.